A phase I/II trial of MEK162 in combination with gemcitabine (G) and cisplatin (C) for patients (pts) with untreated advanced biliary cancer (ABC) Meeting Abstract
| Authors: | Lowery, M. A.; O'Reilly, E. M.; Harding, J. J.; Yu, K. H.; Cercek, A.; Hollywood, E.; Salehi, E.; Margona, E.; Bradley, M.; Witter, T.; Gerst, S. R.; Capanu, M.; Saltz, L.; Abou-Alfa, G. K. |
| Abstract Title: | A phase I/II trial of MEK162 in combination with gemcitabine (G) and cisplatin (C) for patients (pts) with untreated advanced biliary cancer (ABC) |
| Meeting Title: | 2017 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2017 Jan 19-21 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-02-01 |
| Language: | English |
| ACCESSION: | WOS:000443281700282 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2017.35.4_suppl.290 |
| Notes: | Meeting Abstract: 290 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
